flutamide has been researched along with 7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Halushka, PV; Higashiura, K; Mathur, RS; Zucker, TP | 1 |
1 other study(ies) available for flutamide and 7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid
Article | Year |
---|---|
Androstenedione increases thromboxane A2 receptors in human erythroleukemia cells.
Topics: Androgen Antagonists; Androstenedione; Animals; Aorta; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Cells, Cultured; Drug Interactions; Fatty Acids, Unsaturated; Flutamide; Humans; Indomethacin; Iodine Radioisotopes; Kinetics; Leukemia, Erythroblastic, Acute; Muscle, Smooth, Vascular; Radioligand Assay; Rats; Receptors, Thromboxane; Testosterone; Time Factors; Tumor Cells, Cultured | 1996 |